Current Environment: Production

Kiran Maski | Medical Services

Programs & Services

Languages

  • English

Kiran Maski | Education

Medical School

University of Wisconsin Medical School

2004, Madison, WI

Internship

Tufts New England Medical Center

2006, Boston, MA

Residency

Boston Children's Hospital

2009, Boston, MA

Fellowship

Boston Children's Hospital

2010, Boston, MA

Kiran Maski | Certifications

  • American Board of Psychiatry and Neurology (Child and Adolescent Neurology)
  • American Board of Psychiatry and Neurology (Sleep Medicine)

Kiran Maski | Publications

  1. Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric study. J Clin Sleep Med. 2024 Dec 01; 20(12):1887-1893. View Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric study. Abstract

  2. Treating narcolepsy-related nightmares with cognitive behavioural therapy and targeted lucidity reactivation: A pilot study. J Sleep Res. 2024 Oct 22; e14384. View Treating narcolepsy-related nightmares with cognitive behavioural therapy and targeted lucidity reactivation: A pilot study. Abstract

  3. Impaired Sleep-Dependent Memory Consolidation in Pediatric Narcolepsy Type 1. Sleep. 2024 Oct 18. View Impaired Sleep-Dependent Memory Consolidation in Pediatric Narcolepsy Type 1. Abstract

  4. Characterizing disrupted nighttime sleep and associated functional outcomes in youth with narcolepsy type 1. J Clin Sleep Med. 2024 Oct 17. View Characterizing disrupted nighttime sleep and associated functional outcomes in youth with narcolepsy type 1. Abstract

  5. Bipolar Disorder in a female with CDKL5 Deficiency Disorder: A Case Report. Res Sq. 2024 Sep 10. View Bipolar Disorder in a female with CDKL5 Deficiency Disorder: A Case Report. Abstract

  6. Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in children: guidance from the American Academy of Sleep Medicine. J Clin Sleep Med. 2024 Apr 01; 20(4):631-641. View Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in children: guidance from the American Academy of Sleep Medicine. Abstract

  7. Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy. J Clin Sleep Med. 2024 Mar 01; 20(3):445-454. View Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy. Abstract

  8. Central Disorders of Hypersomnolence. Continuum (Minneap Minn). 2023 08 01; 29(4):1045-1070. View Central Disorders of Hypersomnolence. Abstract

  9. A circuit-level biomarker of Rett syndrome based on ectopic phase-amplitude coupling during slow-wave-sleep. Cereb Cortex. 2023 03 10; 33(6):2559-2572. View A circuit-level biomarker of Rett syndrome based on ectopic phase-amplitude coupling during slow-wave-sleep. Abstract

  10. Narcolepsy and Idiopathic Hypersomnia. Sleep Med Clin. 2023 Jun; 18(2):183-199. View Narcolepsy and Idiopathic Hypersomnia. Abstract

  11. Building a deeper understanding of social relationship health in adolescents with narcolepsy disorder. J Clin Sleep Med. 2023 03 01; 19(3):491-498. View Building a deeper understanding of social relationship health in adolescents with narcolepsy disorder. Abstract

  12. Increased incidence of pediatric narcolepsy following the 2009 H1N1 pandemic: a report from the pediatric working group of the sleep research network. Sleep. 2022 09 08; 45(9). View Increased incidence of pediatric narcolepsy following the 2009 H1N1 pandemic: a report from the pediatric working group of the sleep research network. Abstract

  13. Neurobehavioral Associations with NREM and REM Sleep Architecture in Children with Autism Spectrum Disorder. Children (Basel). 2022 Aug 30; 9(9). View Neurobehavioral Associations with NREM and REM Sleep Architecture in Children with Autism Spectrum Disorder. Abstract

  14. How should disrupted nocturnal sleep be characterized in narcolepsy type 1? Sleep. 2022 06 13; 45(6). View How should disrupted nocturnal sleep be characterized in narcolepsy type 1? Abstract

  15. Development and Validation of the Pediatric Hypersomnolence Survey. Neurology. 2022 05 10; 98(19):e1964-e1975. View Development and Validation of the Pediatric Hypersomnolence Survey. Abstract

  16. Dyscoordination of non-rapid eye movement sleep oscillations in autism spectrum disorder. Sleep. 2022 03 14; 45(3). View Dyscoordination of non-rapid eye movement sleep oscillations in autism spectrum disorder. Abstract

  17. Disrupted nighttime sleep and sleep instability in narcolepsy. J Clin Sleep Med. 2022 01 01; 18(1):289-304. View Disrupted nighttime sleep and sleep instability in narcolepsy. Abstract

  18. Harlequin Syndrome, Apnea, and Acute on Chronic Hemiparesis: An Atypical Pediatric Case of Chiari I With Holocord Syringohydromyelia. Pediatr Neurol. 2022 01; 126:108-109. View Harlequin Syndrome, Apnea, and Acute on Chronic Hemiparesis: An Atypical Pediatric Case of Chiari I With Holocord Syringohydromyelia. Abstract

  19. Remote Assessment of Pediatric Patients with Daytime Sleepiness and Healthy Controls: A Pilot Study of Feasibility and Reliability. Child Neurol Open. 2021 Jan-Dec; 8:2329048X211048064. View Remote Assessment of Pediatric Patients with Daytime Sleepiness and Healthy Controls: A Pilot Study of Feasibility and Reliability. Abstract

  20. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021 09 01; 17(9):1881-1893. View Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. Abstract

  21. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021 09 01; 17(9):1895-1945. View Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. Abstract

  22. Abnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome. Mol Autism. 2021 08 03; 12(1):54. View Abnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome. Abstract

  23. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep. 2021 07 09; 44(7). View Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Abstract

  24. Remote Assessment of Cognition in Kids and Adolescents with Daytime Sleepiness: A pilot study of feasibility and reliability. medRxiv. 2021 Mar 26. View Remote Assessment of Cognition in Kids and Adolescents with Daytime Sleepiness: A pilot study of feasibility and reliability. Abstract

  25. Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1. Sleep. 2020 10 13; 43(10). View Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1. Abstract

  26. To split or to lump? Classifying the central disorders of hypersomnolence. Sleep. 2020 08 12; 43(8). View To split or to lump? Classifying the central disorders of hypersomnolence. Abstract

  27. Expanded genetic insight and clinical experience of DNMT1-complex disorder. Neurol Genet. 2020 Aug; 6(4):e456. View Expanded genetic insight and clinical experience of DNMT1-complex disorder. Abstract

  28. COMMENTARY on Lammers et al, Diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence. Sleep Med Rev. 2020 08; 52:101327. View COMMENTARY on Lammers et al, Diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence. Abstract

  29. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol. 2019 12; 6(12):2566-2572. View Children with Narcolepsy type 1 have increased T-cell responses to orexins. Abstract

  30. De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome. Mol Genet Metab Rep. 2018 Sep; 16:23-29. View De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome. Abstract

  31. Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy. J Clin Sleep Med. 2018 02 15; 14(2):245-252. View Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy. Abstract

  32. Pediatric Sleep Disorders. Continuum (Minneap Minn). 2018 02; 24(1, Child Neurology):210-227. View Pediatric Sleep Disorders. Abstract

  33. Impaired memory consolidation in children with obstructive sleep disordered breathing. PLoS One. 2017; 12(11):e0186915. View Impaired memory consolidation in children with obstructive sleep disordered breathing. Abstract

  34. Non-Rapid Eye Movement Arousal Parasomnias in Children. Pediatr Ann. 2017 Sep 01; 46(9):e327-e331. View Non-Rapid Eye Movement Arousal Parasomnias in Children. Abstract

  35. Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy. J Clin Sleep Med. 2017 Mar 15; 13(3):419-425. View Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy. Abstract

  36. Pediatric Sleep Duration Consensus Statement: A Step Forward. J Clin Sleep Med. 2016 12 15; 12(12):1705-1706. View Pediatric Sleep Duration Consensus Statement: A Step Forward. Abstract

  37. Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion. J Clin Sleep Med. 2016 11 15; 12(11):1549-1561. View Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion. Abstract

  38. Corrigendum to "GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease" [Mol. Genet. Metab. 111 (2014) 393-398]. Mol Genet Metab. 2016 11; 119(3):293. View Corrigendum to "GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease" [Mol. Genet. Metab. 111 (2014) 393-398]. Abstract

  39. Insomnia, parasomnias, and narcolepsy in children: clinical features, diagnosis, and management. Lancet Neurol. 2016 10; 15(11):1170-81. View Insomnia, parasomnias, and narcolepsy in children: clinical features, diagnosis, and management. Abstract

  40. Recommended Amount of Sleep for Pediatric Populations: A Consensus Statement of the American Academy of Sleep Medicine. J Clin Sleep Med. 2016 06 15; 12(6):785-6. View Recommended Amount of Sleep for Pediatric Populations: A Consensus Statement of the American Academy of Sleep Medicine. Abstract

  41. Sleep Dependent Memory Consolidation in Children with Autism Spectrum Disorder. Sleep. 2015 Dec 01; 38(12):1955-63. View Sleep Dependent Memory Consolidation in Children with Autism Spectrum Disorder. Abstract

  42. Understanding Racial Differences in Narcolepsy Symptoms May Improve Diagnosis. Sleep. 2015 Nov 01; 38(11):1663-4. View Understanding Racial Differences in Narcolepsy Symptoms May Improve Diagnosis. Abstract

  43. Usefulness of a Nocturnal SOREMP for Diagnosing Narcolepsy with Cataplexy in a Pediatric Population. Sleep. 2015 Jun 01; 38(6):859-65. View Usefulness of a Nocturnal SOREMP for Diagnosing Narcolepsy with Cataplexy in a Pediatric Population. Abstract

  44. Sleep-Dependent Memory Consolidation in Children. Semin Pediatr Neurol. 2015 Jun; 22(2):130-4. View Sleep-Dependent Memory Consolidation in Children. Abstract

  45. Quality measures for the care of patients with narcolepsy. J Clin Sleep Med. 2015 Mar 15; 11(3):335. View Quality measures for the care of patients with narcolepsy. Abstract

  46. Drug testing in children with excessive daytime sleepiness during multiple sleep latency testing. J Clin Sleep Med. 2014 Aug 15; 10(8):897-901. View Drug testing in children with excessive daytime sleepiness during multiple sleep latency testing. Abstract

  47. Increased pediatric functional neurological symptom disorders after the Boston marathon bombings: a case series. Pediatr Neurol. 2014 Nov; 51(5):619-23. View Increased pediatric functional neurological symptom disorders after the Boston marathon bombings: a case series. Abstract

  48. Copy number variation plays an important role in clinical epilepsy. Ann Neurol. 2014 Jun; 75(6):943-58. View Copy number variation plays an important role in clinical epilepsy. Abstract

  49. Clinical reasoning: a 14-year-boy with spells of somnolence and cognitive changes. Neurology. 2014 Apr 22; 82(16):e142-6. View Clinical reasoning: a 14-year-boy with spells of somnolence and cognitive changes. Abstract

  50. Functional neurological symptom disorders in a pediatric emergency room: diagnostic accuracy, features, and outcome. Pediatr Neurol. 2014 Aug; 51(2):233-8. View Functional neurological symptom disorders in a pediatric emergency room: diagnostic accuracy, features, and outcome. Abstract

  51. Development and implementation of a quality improvement curriculum for child neurology residents: lessons learned. Pediatr Neurol. 2014 May; 50(5):452-7. View Development and implementation of a quality improvement curriculum for child neurology residents: lessons learned. Abstract

  52. GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease. Mol Genet Metab. 2014 03; 111(3):393-398. View GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease. Abstract

  53. Sleep deprivation and neurobehavioral functioning in children. Int J Psychophysiol. 2013 Aug; 89(2):259-64. View Sleep deprivation and neurobehavioral functioning in children. Abstract

  54. Common neurological co-morbidities in autism spectrum disorders. Curr Opin Pediatr. 2011 Dec; 23(6):609-15. View Common neurological co-morbidities in autism spectrum disorders. Abstract

  55. Intracranial artery dissection in an adolescent with Marfan syndrome. Pediatr Neurol. 2011 Jul; 45(1):39-41. View Intracranial artery dissection in an adolescent with Marfan syndrome. Abstract

  56. New onset epilepsy in Prader-Willi syndrome: semiology and literature review. Pediatr Neurol. 2010 Oct; 43(4):297-9. View New onset epilepsy in Prader-Willi syndrome: semiology and literature review. Abstract

  57. Epilepsy in Prader-Willi syndrome: clinical characteristics and correlation to genotype. Epilepsy Behav. 2010 Nov; 19(3):306-10. View Epilepsy in Prader-Willi syndrome: clinical characteristics and correlation to genotype. Abstract

  58. Child neurology: past, present, and future: part 2: Present training structure. Neurology. 2010 Feb 09; 74(6):e17-9. View Child neurology: past, present, and future: part 2: Present training structure. Abstract

  59. Searching for marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Sleep. 2009 Feb; 32(2):137. View Searching for marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Abstract

There is an abundance of research showing the effects of sleep on daytime cognition, behavior and mood. Improving patients sleep can not only help the child in these domains but also family functioning.

BESbswy